| Literature DB >> 22749629 |
Woo-Joo Choi1, Min-Jee Kim, Chulho Kim, Jong Hee Sohn, Hui-Chul Choi.
Abstract
Intravenous immunoglobulins (IVIGs) are used for a variety of immunologic and hematologic disorders. Hemorheologic alteration or the rapid increase of platelet counts by IVIG administration can cause thrombotic adverse events. We present a 58-year-old woman with a previous diagnosis of idiopathic thrombocytopenic purpura who developed cerebellar infarction immediately after IVIG treatment. We discuss a possible role of IVIG in cerebral ischemia and management strategies.Entities:
Mesh：
Substances：
Year: 2012 PMID： 22749629 DOI： 10.1016/j.jstrokecerebrovasdis.2012.05.006
Source DB: PubMed Journal: J Stroke Cerebrovasc Dis ISSN： 1052-3057 Impact factor: 2.136